Meeting
2024 ASCO Annual Meeting
Real-world ctDNA testing patterns, associated biomarkers and sites of metastasis in early stage colorectal cancer.
Authors
Erin Fidyk
Flatiron Health, New York, NY
Erin Fidyk , Laurynas Kalesinskas , Konstantin Krismer , Auriane Blarre , Lilia Bouzit , John James Ritten , Anca Marinescu , Jonathan Kelly , Katherine Harrison , Aaron B. Cohen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 3610)
DOI
10.1200/JCO.2024.42.16_suppl.3610
Abstract #
3610
Poster Bd #
273
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Metastatic bulk to predict subclonal heterogeneity by ctDNA in RAS/RAF-wildtype colorectal cancer.
First Author: Jeremy D. Kratz
Poster
2021 ASCO Annual Meeting
Minimal residual disease (MRD) in patients with resected stage I NSCLC: Results of the prospective adjuvant IFCT-0703 trial.
First Author: Damien Vasseur
Poster
2020 ASCO Virtual Scientific Program
Tumor-informed assessment of molecular residual disease and its incorporation into practice for patients with early and advanced-stage colorectal cancer (CRC-MRD Consortia).
First Author: Pashtoon Murtaza Kasi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
SBRT with ipilimumab and nivolumab to metastatic MSS colorectal and pancreatic cancer: A pooled analysis of four prospective phase II trials.
First Author: Hannah Johnson Roberts